Rainbow Childrens Medicare Intrinsic Value
Rainbow Childrens Medicare intrinsic value. Rainbow Childrens Medicare (RAINBOW) median intrinsic value is ₹500.58 from 10 valuation models (range ₹326–₹713), vs current price ₹1240.80 — -59.7% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse RAINBOW shareholding pattern to track promoter, FII and institutional holdings.
RAINBOW Valuation Methods Summary — DCF, Graham Number & P/E
Rainbow Childrens Medicare intrinsic value across 10 models vs current price ₹1240.80 — upside/downside and value range per method. For current market price and key ratios, visit Rainbow Childrens Medicare share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹712.80 | ₹570.24 - ₹855.36 | -42.6% | EPS: ₹32.40, Sector P/E: 22x |
| Book Value Method | asset | ₹326.27 | ₹293.64 - ₹358.90 | -73.7% | Book Value/Share: ₹163.14, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹436.08 | ₹392.47 - ₹479.69 | -64.9% | Revenue/Share: ₹218.04, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹698.04 | ₹628.24 - ₹767.84 | -43.7% | EBITDA: ₹712.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹559.31 | ₹447.45 - ₹671.17 | -54.9% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹372.24 | ₹335.02 - ₹409.46 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹500.58 | ₹450.52 - ₹550.64 | -59.7% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹620.40 | ₹558.36 - ₹682.44 | -50.0% | ROE: 20.2%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹372.24 | ₹335.02 - ₹409.46 | -70.0% | EPS: ₹32.40, BVPS: ₹163.14 |
| Dividend Yield Method | dividend | ₹372.24 | ₹335.02 - ₹409.46 | -70.0% | DPS: ₹3.50, Target Yield: 2.5% |
RAINBOW Intrinsic Value vs Market Price — All Valuation Models
Rainbow Childrens Medicare fair value range ₹326–₹713 vs current market price ₹1240.80 across 10 valuation models. Browse RAINBOW balance sheet details for revenue, profit, balance sheet and cash flow data.
RAINBOW Intrinsic Value Analysis — Undervalued or Overvalued?
Rainbow Childrens Medicare median intrinsic value ₹500.58, current price ₹1240.80 — Trading Above Calculated Value by 59.7%, margin of safety -100.0%.
What is the intrinsic value of RAINBOW?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Rainbow Childrens Medicare (RAINBOW) is ₹500.58 (median value). With the current market price of ₹1240.80, this represents a -59.7% variance from our estimated fair value.
The valuation range spans from ₹326.27 to ₹712.80, indicating ₹326.27 - ₹712.80.
Is RAINBOW undervalued or overvalued?
Based on our multi-method analysis, Rainbow Childrens Medicare (RAINBOW) appears to be trading above calculated value by approximately 59.7%.
RAINBOW Financial Health — Key Ratios vs Industry Benchmarks
Rainbow Childrens Medicare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 20.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 31.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.80x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
RAINBOW Cash Flow Quality — Operating & Free Cash Flow
Rainbow Childrens Medicare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹420 Cr | ₹291 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹396 Cr | ₹262 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹321 Cr | ₹208 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹329 Cr | ₹97 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹224 Cr | ₹137 Cr | Positive Free Cash Flow | 8/10 |